And GLP-1 medications like Foundayo address appetite regulation and how the body processes food
In June of 2021, the FDA approved Wegovy (semaglutide), a weekly injectible
All four drugs Ozempic, Wegovy, Mounjaro and Zepbound still remain on the health regulators drug shortage, despite all but one dose of Wegovy being listed as currently available on the site
There have been concerns that GLP-1RAs may increase the risk of intestinal obstruction
All four medications belong to the GLP-1 category, but they have different uses and active ingredients: Ozempic (semaglutide): Approved for type 2 diabetes, often used off-label for weight loss
Germany remains important as a high-spec market for wellness nutrition and pharmacy-adjacent products